Citation data

CrossRef

Works that cite this article, indexed by Crossref.

5 resultsUpdated October 25, 2026

← Back to article

1

Lenvatinib-Associated Posterior Reversible Encephalopathy Syndrome in a Patient With Metastatic Clear Cell Renal Cell Carcinoma: A Case Report

Cureus (2026)

Nasong A Luginaah; Aquila Akingbade; Seth Climans

2

Posterior Reversible Encephalopathy Syndrome (PRES) Associated With Lenvatinib: A Disproportionality Analysis

Journal of Pharmacy Technology 42(5) (2026)

Eleonora Castellana; Maria Rachele Chiappetta

3

Iodine-131/lenvatinib/sorafenib

Reactions Weekly 1973(1) (2023)

4

Posterior Reversible Encephalopathy Syndrome with Angiogenesis Inhibitors for Solid Tumours: Clues from a Disproportionality Analysis of the FDA Adverse Event Reporting System and Pharmacodynamics

Targeted Oncology 21(3) (2026)

Monia Donati; Chiara Cancellerini; Valentina Giunchi; Simone Rossi; Francesco Massari; Francesco Gelsomino; Elisabetta Poluzzi; Emanuel Raschi

5

In vitro Multi-targeted Anti-cancer Effects of Bavachinin in Papillary Thyroid Carcinoma Cell Line: Dual Pathway Inhibition and Cytokine Downregulation

Iranian Journal of Pharmaceutical Research 24(1) (2025)

Gang Duan; Zahra Zahid Piracha; Umar Saeed; Yanrong Tian